The annual laboratory equipment exhibition, Medlab Middle East, took place on 3-5 February 2025 at Dubai World Trade Centre in Dubai, United Arab Emirates (UAE), uniting with the World Health Expo (WHX) to foster greater global collaboration, innovation, and impact in the laboratory industry. As one of the world’s leading medical laboratory exhibitions, Medlab Middle East traditionally attracts both laboratory equipment manufacturers and users (physicians, biologists, technicians) from all over the world, including Asia, Europe, South America and North America. This year’s edition welcomed over 800 exhibitors from more than 40 countries to showcase the latest innovations and technologies in the field of medical laboratory.
The exhibition traditionally includes scientific sessions and presentations on a variety of subjects, with a significant proportion of these presentations focusing on automation, 'smart' solutions and the use of artificial intelligence for diagnostic purposes. Within the framework of the “Revolutionizing Diagnostics with the Help of Technologies” session, which formed part of the 'Lab Automation Track', a development made at Almazov Centre was presented: a calculator for calculating the probability of venous thromboembolic complications in patients with CNS glial tumors. Yulia Zhilenkova, Associate Professor of the Department of Laboratory Medicine, presented the results of the team of authors, who developed the «GliomaRiskThrombosis Calculator», which was carried out as part of WCRC for Personalized Medicine project led by Maria Simakova, Senior Researcher and Head of the Cardio-Oncology Research Group.
The presentation made by the specialists from Almazov Centre was met with significant interest and acclaim by the audience. It is noteworthy that the authors were personally invited by the session moderators to deliver their presentation, underscoring the current relevance of the subject matter, namely 'smart' solutions in medical and laboratory practice.